Literature DB >> 5944111

Surgical treatment of supravalvular aortic stenosis. Report of 16 cases and review of literature.

G C Rastelli, D C McGoon, P A Ongley, H T Mankin, J W Kirklin.   

Abstract

Entities:  

Mesh：

Year:  1966        PMID： 5944111

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN： 0022-5223            Impact factor:   5.209


× No keyword cloud information.
  8 in total

1.  Supravalvar aortic stenosis.

Authors:  E C Martin; I F Moseley
Journal:  Br Heart J       Date:  1973-07

Review 2.  Left ventricular outflow obstruction.

Authors:  R Arnold; D Kitchiner
Journal:  Arch Dis Child       Date:  1995-02       Impact factor: 3.791

3.  Prognosis of supravalve aortic stenosis in 81 patients in Liverpool (1960-1993).

Authors:  D Kitchiner; M Jackson; K Walsh; I Peart; R Arnold
Journal:  Heart       Date:  1996-04       Impact factor: 5.994

4.  [Reoperation for diffuse supravalvular aortic stenosis with Williams syndrome--extended patch aortoplasty and extra-anatomic bypass from the ascending aorta to the descending aorta in a median sternotomy].

Authors:  Y Kumada; H Yasuda; E Sasaki; S Murakawa; Y Mori; H Hirose
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1998-10

5.  The role of rubella in the etiology of supravalvular aortic stenosis.

Authors:  D J Vince
Journal:  Can Med Assoc J       Date:  1970-11-21       Impact factor: 8.262

6.  Growth of the aorta in children with Williams syndrome: does surgery make a difference?

Authors:  R F English; S D Colan; P M Kanani; J A Ettedgui
Journal:  Pediatr Cardiol       Date:  2003-04-30       Impact factor: 1.655

7.  Assessment of three types of surgical procedures for supravalvar aortic stenosis: A systematic review and meta-analysis.

Authors:  Lizhi Lv; Xinyue Lang; Simeng Zhang; Cheng Wang; Qiang Wang
Journal:  Front Cardiovasc Med       Date:  2022-09-06

Review 8.  Williams syndrome.

Authors:  Beth A Kozel; Boaz Barak; Chong Ae Kim; Carolyn B Mervis; Lucy R Osborne; Melanie Porter; Barbara R Pober
Journal:  Nat Rev Dis Primers       Date:  2021-06-17       Impact factor: 65.038
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.